| Study summary: |
|
The purpose of this study is to determine the efficacy, safety, and tolerability of different doses of JNJ-27018966 compared with placebo in the treatment of patients with irritable bowel syndrome with diarrhea (IBS-d). |
| Qualified participants must: |
|
• Have a diagnosis of IBS by Rome III criteria with a subtype of diarrhea
•
Have an average daily pain score of ≥3.0 on a 0- to 10-point scale over the past week
•
Have a weekly mean stool consistency score (BSS) of ≥5.5 over the past week
•
If female, be postmenopausal, defined as amenorrhea for at least 2 years, at pre-screening
•
If female, be surgically sterile (have had a hysterectomy or bilateral oophorectomy, tubal ligation, or otherwise be incapable of pregnancy)
•
If female, be abstinent, or if sexually active, be practicing an effective method of birth control
|
| Participants may receive: |
|
Study related care, diagnostic tests, and study medication at no cost. Payment for time and travel to the study center may be provided. |
| Study is available at: |
|
Providence Clinical Research
3808 W. Riverside Drive
Suite 200
Burbank, CA 91505
View Clinic Location
If you meet the above criteria and live within 50 miles of this clinic please enter your information below and click "I Am Interested In This Study" to be contacted by the study coordinator.
or
Click "View Contact Phone Number" to get the clinic’s phone number. |